Stay updated with breaking news from Co Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) was the target of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 857,900 shares, a drop of 19.8% from the March 31st total of 1,070,000 shares. Based on an average daily volume of 142,600 shares, the short-interest […]
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating)’s share price fell 4% on Friday . The stock traded as low as $1.45 and last traded at $1.45. 64,562 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 135,768 shares. The stock had previously closed at $1.51. Analysts Set New Price […]
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) was the target of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 1,040,000 shares, a drop of 20.6% from the February 28th total of 1,310,000 shares. Based on an average trading volume of 135,600 shares, the days-to-cover […]
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) saw a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 1,040,000 shares, a drop of 20.6% from the February 28th total of 1,310,000 shares. Based on an average daily trading volume, of 135,600 shares, the short-interest ratio is […]